Abstract
BACKGROUND: Although the benefits of prostate cancer screening are uncertain and guidelines recommend that physicians share the screening decision with their patients, most U.S. men over age 50 are routinely screened, often without counseling.
OBJECTIVE: To develop an instrument for assessing physicians’ knowledge related to the U.S. Preventive Services Task Force recommendations on prostate cancer screening.
PARTICIPANTS: Seventy internists, family physicians, and general practitioners in the Los Angeles area who deliver primary care to adult men.
MEASUREMENTS: We assessed knowledge related to prostate cancer screening (natural history, test characteristics, treatment effects, and guideline recommendations), beliefs about the net benefits of screening, and prostate cancer screening practices for men in different age groups, using an online survey. We constructed a knowledge scale having 15 multiple-choice items.
RESULTS: Participants’ mean knowledge score was 7.4 (range 3 to 12) of 15 (Cronbach’s α=0.71). Higher knowledge scores were associated with less belief in a mortality benefit from prostate-specific antigen (PSA) testing (r=−.49, P<.001). Participants could be categorized as low, age-selective, and high users of routine PSA screening. High users had lower knowledge scores than age-selective or low users, and they believed much more in mortality benefits from PSA screening.
CONCLUSIONS: Based on its internal consistency and its correlations with measures of physicians’ net beliefs and self-reported practices, the knowledge scale developed in this study holds promise for measuring the effects of professional education on prostate cancer screening. The scale deserves further evaluation in broader populations.
Similar content being viewed by others
References
Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I: prior probability and effectiveness of tests. The American college of physicians. Ann Intern Med. 1997;126:394–406.
Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive services task force. Ann Intern Med. 2002;137:917–29.
McNaughton-Collins M, Fowler FJ Jr., Caubet JF, et al. Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med. 2004;117:719–25.
U.S. Preventive Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002;137:915–6.
American Urological Association (AUA). Prostate-specific antigen (PSA) best practice policy. Oncology (Huntington). 2000;14:267–80.
Smith RA, Cokkinides V, Eyre HJ. American cancer society guidelines for the early detection of cancer, 2004. CA Cancer J Clin. 2004;54:41–52.
Frosch DL, Kaplan RM. Shared decision making in clinical medicine: past research and future directions. Am J Prev Med. 1999;17:285–94.
Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–65.
Hoffman RM, Papenfuss MR, Buller DB, Moon TE. Attitudes and practices of primary care physicians for prostate cancer screening. Am J Prev Med. 1996;12:277–81.
Austin OJ, Valente S, Hasse LA, Kues JR. Determinants of prostatespecific antigen test use in prostate cancer screening by primary care physicians. Arch Family Med. 1997;6:453–8.
Flower FJ Jr., Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104:526–32.
Voss JD, Schectman JM. Prostate cancer screening practices and beliefs. J Gen Intern Med. 2001;16:831–7.
Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA. 2003;289:1414–20.
Arias E. United States Life Tables, 2000. National Vital Statistics Reports, Vol. 51. Hyattsville, MD: National Center for Health Statistics; 2002.
Federman DG, Goyal S, Kamina A, Peduzzi P, Concato J. Informed consent for PSA screening: does it happen. Effect Clin Pract. 1999;2:152–7.
Chan EC, Vernon SW, Ahn C, Greisinger A. Do men know that they have had a prostate-specific antigen test? Accuracy of self-reports of testing at 2 sites. Am J Public Health. 2004;94:1336–8.
Dulai GS, Farmer MM, Ganz PA, et al. Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting. Cancer. 2004;100:1843–52.
Degner LF, Sloan JA. Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol. 1992;45:941–50.
American Medical Association. AMA Physician Masterfile. Available at: http://www.ama-assn.org/ama/pub/category/2673.html. Accessed February 12, 2005.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297.
Nunnally JC, Bernstein IH. Psychometric Theory. New York: McGraw-Hill; 1994.
Cronbach LJ, Meehl PE. Construct validity in psychological tests. Psychol Bull. 1955;52:281–302.
Sorum PC, Shim J, Chasseigne G, Bonnin-Scaon S, Cogneau J, Mullet E. Why do primary care physicians in the United States and France order prostate-specific antigen tests for asymptomatic patients? Med Decis Making. 2003;23:301–13.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no conflict of interest to declare for this article.
This study was supported by the U.S. Centers for Disease Control (cooperative agreement U58-CCU920367), and by the National Center for Research Resources (grant G12 RR 03026-13). Dr. Bell had additional support from the Robert Wood Johnson Foundation Generalist Faculty Physician Scholars Program and Dr. Hays from the UCLA/DREW Project EXPORT, National Institutes of Health, National Center on Minority Health & Health Disparities, (P20-MD00148-01), and the UCLA Center for Health Improvement in Minority Elders/Resource Centers for Minority Aging Research.
Rights and permissions
About this article
Cite this article
Bell, D.S., Hays, R.D., Hoffman, J.R. et al. A test of knowledge about prostate cancer screening. J Gen Intern Med 21, 310–314 (2006). https://doi.org/10.1111/j.1525-1497.2006.00337.x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2006.00337.x